Stay tuned for our LIVE OncLive News Network coverage straight from the #ASH18 conference floor! 

Dr. Woodward on Radiotherapy in Breast Cancer

Wendy A. Woodward, MD, PhD
Published: Thursday, Jul 12, 2018



Wendy A. Woodward, MD, PhD, professor and chief, Clinical Breast Radiotherapy Service, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, discusses radiotherapy in breast cancer.

The EORTC 22922 trial recently presented at the 2018 ASCO Annual Meeting randomized patients with stage I-III disease who were node-positive and had central or medial tumors to regional nodal irradiation. The primary endpoint was overall survival. The primary finding showed that at 15 years, breast cancer mortality was improved by 3.8% in the patients who received regional nodal irradiation, says Woodward. These results, in combination with another trial, demonstrate that radiotherapy has a systemic effect in these early-stage patients, explains Woodward.

However, one of the challenges of regional nodal irradiation is the impact on the heart. Though the trial did not see worse cardiac outcomes, they did see an increased number of deaths in the regional nodal irradiation arm from unknown causes. In contemporary practice, Woodward states that there is a lot of effort that goes into reducing the dose to the heart. That can be done with a deep inspiration breath hold and more advanced technologies, says Woodward. In current practice, physicians estimate the risk of a heart event to be less than 1%.


Wendy A. Woodward, MD, PhD, professor and chief, Clinical Breast Radiotherapy Service, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, discusses radiotherapy in breast cancer.

The EORTC 22922 trial recently presented at the 2018 ASCO Annual Meeting randomized patients with stage I-III disease who were node-positive and had central or medial tumors to regional nodal irradiation. The primary endpoint was overall survival. The primary finding showed that at 15 years, breast cancer mortality was improved by 3.8% in the patients who received regional nodal irradiation, says Woodward. These results, in combination with another trial, demonstrate that radiotherapy has a systemic effect in these early-stage patients, explains Woodward.

However, one of the challenges of regional nodal irradiation is the impact on the heart. Though the trial did not see worse cardiac outcomes, they did see an increased number of deaths in the regional nodal irradiation arm from unknown causes. In contemporary practice, Woodward states that there is a lot of effort that goes into reducing the dose to the heart. That can be done with a deep inspiration breath hold and more advanced technologies, says Woodward. In current practice, physicians estimate the risk of a heart event to be less than 1%.



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Miami Breast Cancer Conference®: Attendee Tumor Board OnlineNov 30, 20181.5
Community Practice Connections™: 1st Annual Paris Breast Cancer Conference™Dec 31, 20181.5
Publication Bottom Border
Border Publication
x